272 related articles for article (PubMed ID: 16569390)
1. Combined modality therapy of localized gastric and esophageal cancers.
Das P; Fukami N; Ajani JA
J Natl Compr Canc Netw; 2006 Apr; 4(4):375-82. PubMed ID: 16569390
[TBL] [Abstract][Full Text] [Related]
2. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Varadhachary G; Ajani JA
Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
[TBL] [Abstract][Full Text] [Related]
3. [Perioperative therapy in esophageal and stomach carcinoma].
Stahl M; Wilke H; Meyer HJ
Med Klin (Munich); 1996 Apr; 91 Suppl 3():85-92. PubMed ID: 8692126
[No Abstract] [Full Text] [Related]
4. For localized gastroesophageal cancer, you give chemoradiation before surgery, but then what happens?
Ajani JA; Correa AM; Swisher SG; Wu TT
J Clin Oncol; 2007 Sep; 25(27):4315-6. PubMed ID: 17878485
[No Abstract] [Full Text] [Related]
5. Controversies in the treatment of local and locally advanced gastric and esophageal cancers.
Cohen DJ; Leichman L
J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302
[TBL] [Abstract][Full Text] [Related]
6. Multimodality treatment for localized gastro-oesophageal cancer.
Okines AF; Cunningham D
Ann Oncol; 2010 Oct; 21 Suppl 7():vii286-93. PubMed ID: 20943630
[TBL] [Abstract][Full Text] [Related]
7. Combined-modality therapy for esophageal and gastroesophageal junction cancers.
Yoon HH; Gibson MK
Curr Oncol Rep; 2007 May; 9(3):184-92. PubMed ID: 17430689
[TBL] [Abstract][Full Text] [Related]
8. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary approach to esophageal and gastric cancer.
Stein HJ; Sendler A; Fink U; Siewert JR
Surg Clin North Am; 2000 Apr; 80(2):659-82; discussions 683-6. PubMed ID: 10836011
[TBL] [Abstract][Full Text] [Related]
10. Time to adjuvant therapy and other variables in localized gastric and gastroesophageal junction (GEJ) cancer (IJGC-D-13-00162).
Ahmed S; Iqbal N; Yadav S; Zaidi A; Ahmed O; Alvi R; Gardner D; Haider K
J Gastrointest Cancer; 2014 Sep; 45(3):284-90. PubMed ID: 24493115
[TBL] [Abstract][Full Text] [Related]
11. Cancer of the esophagus and gastric cardia: recent advances.
Tytgat GN; Bartelink H; Bernards R; Giaccone G; van Lanschot JJ; Offerhaus GJ; Peters GJ
Dis Esophagus; 2004; 17(1):10-26. PubMed ID: 15209736
[TBL] [Abstract][Full Text] [Related]
12. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen.
Yang Q; Cleary KR; Yao JC; Swisher SG; Roth JA; Lynch PM; Komaki R; Ajani JA; Rashid A; Hamilton SR; Wu TT
Dis Esophagus; 2004; 17(1):38-43. PubMed ID: 15209739
[TBL] [Abstract][Full Text] [Related]
13. [Stomach and esophageal neoplasm. Changes over 16 years in clinical materials].
Polkowski W; Ciechański A; Wallner G; Dabrowski A; Pawłowski A; Chibowski D; Misiuna P
Wiad Lek; 1997; 50 Suppl 1 Pt 2():388-93. PubMed ID: 9424909
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy in esophageal cancer.
Picone V; D'Auria G; Ferraldeschi R; Grande R; Passeri V; Ranuncoli A; Di Bartolomeo C; Evangelista ML; Cortesi E
Rays; 2006; 31(1):31-5. PubMed ID: 16999373
[TBL] [Abstract][Full Text] [Related]
15. Multimodality therapy for cancers of the esophagus and gastric cardia.
Naughton P; Walsh TN
Expert Rev Anticancer Ther; 2004 Feb; 4(1):141-50. PubMed ID: 14748664
[TBL] [Abstract][Full Text] [Related]
16. [Current diagnosis and therapy of esophageal carcinoma].
Mühr-Wilkenshoff F; Stahl M; Faiss S; Zeitz M; Scherübl H
Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
[TBL] [Abstract][Full Text] [Related]
17. [Radiotherapy in cancers of the oesophagus, the gastric cardia and the stomach].
Créhange G; Huguet F; Quero L; N'Guyen TV; Mirabel X; Lacornerie T
Cancer Radiother; 2016 Sep; 20 Suppl():S161-8. PubMed ID: 27523409
[TBL] [Abstract][Full Text] [Related]
18. Management of locoregional stage esophageal cancer: a single center experience.
Javle MM; Nwogu CE; Donohue KA; Iyer RV; Brady WE; Khemka SV; Smith JL; Demmy TL; Yang GY; Nava HR
Dis Esophagus; 2006; 19(2):78-83. PubMed ID: 16643174
[TBL] [Abstract][Full Text] [Related]
19. Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer.
Bolm L; Käsmann L; Paysen A; Karapetis C; Rades D; Wellner UF; Keck T; Watson DI; Hummel R; Hussey DJ
Anticancer Res; 2018 Jun; 38(6):3231-3242. PubMed ID: 29848670
[TBL] [Abstract][Full Text] [Related]
20. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F;
Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
